RAFAEL HOLDINGS, INC. Conversion of Stock, Shares Issued
RAFAEL HOLDINGS, INC. (RFL) reported Conversion of Stock, Shares Issued of 46.13 thousand shares for the 9-month period ending 2024-04-30, per its 10-Q filed 2024-06-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2024-06-14
- RAFAEL HOLDINGS, INC. conversion of stock, shares issued for the quarter ending 2024-04-30 was 0.00 shares.
- RAFAEL HOLDINGS, INC. conversion of stock, shares issued for the quarter ending 2024-01-31 was 0.00 shares.
- RAFAEL HOLDINGS, INC. conversion of stock, shares issued for the quarter ending 2023-10-31 was 46.13K shares.
- RAFAEL HOLDINGS, INC. conversion of stock, shares issued for the quarter ending 2023-04-30 was -25.00K shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month |
|---|---|---|---|
| 2024-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-06-14 | 46.13K shares 10-Q · filed 2024-06-14 |
| 2024-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | 46.13K shares 10-Q · filed 2024-03-14 | |
| 2023-10-31 | 46.13K shares 10-Q · filed 2023-12-14 | ||
| 2023-04-30 | -25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | 928.81K shares 10-Q · filed 2023-06-13 | |
| 2023-01-31 | 953.81K shares 10-Q · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |